Son of former Bengals RB Ickey Woods dies at 16 after asthma attack – USA Today


kypost.com

Son of former Bengals RB Ickey Woods dies at 16 after asthma attack
USA Today
The son for former NFL running back Ickey Woods died after complications from an asthma attack on Saturday night. Elbert Jovante Woods was 16 and was a
Reports: Former Cincinnati Bengals receiver Ickey Woods' son dies after asthma ESPN
Student Athlete Dies From Asthma AttackAbout – News & Issues (blog)
Former Bengal's Son Dies After Asthma AttackWLWT Cincinnati
ProFootballTalk –WKRC TV Cincinnati –Cincinnati.com (blog)
all 16 news articles »

View full post on asthma – Google News

Reports: Former Cincinnati Bengals receiver Ickey Woods’ son dies after asthma … – ESPN


kypost.com

Reports: Former Cincinnati Bengals receiver Ickey Woods' son dies after asthma
ESPN
Jovante was taken to at Cincinnati Children's Hospital Medical Center on Wednesday after suffering an asthma attack. He had practiced with the Princeton
Ickey Woods' son passes awayProFootballTalk
Joe Woods Death Could Save Eight OthersWKRC TV Cincinnati
Sad news …Cincinnati.com (blog)
kypost.com –FanHouse –Cincinnati.com
all 12 news articles »

View full post on asthma – Google News

Enhanced Asthma Treatments After A More Complete Scope – allvoices

Enhanced Asthma Treatments After A More Complete Scope
allvoices
Current estimates indicate that 23.2 million adults and 9 million children in the United States endure lifetime asthma.
Dramatically Improved Treatment Expected Following More Detailed Picture Of AsthmaMedical News Today
Experts unravel a clearer picture of asthma, can apparently improve treatmentHealthJockey.com

all 3 news articles »

View full post on asthma – Google News

After 40 Years, NIH-Supported Researchers Identify Possible New Treatment for Severe Vasculitis

Investigators have made a major advance in treating people with a severe form of vasculitis, anti-neutrophil cytoplasmic antibody (ANCA)-associated vasculitis, a rare but devastating disease of blood vessels. In a six-month study, a new treatment strategy provided the same benefits as the current standard of care used for more than 40 years but required less frequent treatments. Early results also suggest that patients with disease relapses — typically recurrences of fever, fatigue, kidney damage, or bleeding in the lungs — respond better to the new regimen.

View full post on National Institutes of Health (NIH) News Releases